📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes. (2021)

First Author: Pearson JA

Attributed to: Can microbiota modulate circadian oscillations to alter susceptibility to autoimmunity? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/immadv/ltab024

PubMed Identifier: 35156097

Publication URI: http://europepmc.org/abstract/MED/35156097

Type: Journal Article/Review

Volume: 1

Parent Publication: Immunotherapy advances

Issue: 1

ISSN: 2732-4303